| 
                Clerk of the House of Representatives Legislative Resource Center 135 Cannon Building Washington, DC 20515 http://lobbyingdisclosure.house.gov  | 
                Secretary of the Senate Office of Public Records 232 Hart Building Washington, DC 20510 http://www.senate.gov/lobby  | 
LOBBYING REGISTRATION
Lobbying Disclosure Act of 1995 (Section 4)
| 1. Effective Date of Registration | 2/1/2015  | 
||||
| 2. House Identification |  34528  | 
Senate Identification |  48827  | 
||
REGISTRANT Organization/Lobbying Firm Self Employed Individual
| 3. Registrant | Organization | Ogilvy Government Relations  | 
||||
| Address | 1111 19th Street, NW  | 
Address2 | Suite 1100  | 
| City | Washington  | 
State | DC  | 
Zip | 20036  | 
Country | USA  | 
4. Principal place of business (if different than line 3)
| City | 
    | 
State | 
    | 
Zip | 
    | 
Country | 
    | 
| 5. Contact name and telephone number | International Number | 
| Contact | Ms. Rawson Hart  | 
Telephone | 2027294200  | 
rawson.hart@ogilvygr.com  | 
CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self
| 7. Client name | Novartis Services, Inc.  | 
| Address | 701 Pennsylvania Ave, NW, Suite 725  | 
| City | Washington  | 
State | DC  | 
Zip | 20004  | 
Country | USA  | 
| City | 
    | 
State | 
    | 
Zip | 
    | 
Country | 
    | 
LOBBYISTS
10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.
| Name | Covered Official Position (if applicable) | ||
First  | 
Last  | 
Suffix  | 
|
| Karissa | Willhite |  | Menendez:DepCOS,DepExecDirHouseDemCauc,LA;Stenholm:LA | 
| Moses | Mercado |  | Dep Chief of Staff, Gephardt; Chief of Staff, Green | 
| Bud | Albright |  | UnderSecretary,DeptofEnergy;RepubStaffDir,HouseEnergy&Comm; | 
| Bud | Albright |  | Sr.OversightCouns,HouseCommerceComm;ChiefCouns,HouseCommDC | 
|  |  |  |  | 
LOBBYING ISSUES
11. General lobbying issue areas (Select all applicable codes).
HCR  | 
      | 
      | 
      | 
      | 
      | 
      | 
      | 
      | 
12. Specific lobbying issues (current and anticipated)
general healthcare issues
AFFILIATED ORGANIZATIONS
13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?
| No --> Go to line 14. | Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14. | 
| Internet Address: | 
    | 
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
  | 
||||||||||
        | 
        | 
  | 
||||||||
  | 
  | 
|||||||||
        | 
        | 
  | 
||||||||
  | 
  | 
|||||||||
        | 
        | 
  | 
||||||||
  | 
  | 
FOREIGN ENTITIES
14. Is there any foreign entity
a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or
b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or
c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?
| No --> Sign and date the registration. | Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration. | 
| Address | Ownership | |||||
| Name | Street | Principal place of business | Amount of contribution | |||
  | 
(city and state or country) | for lobbying activities | ||||
Fabrikstrasse 2  | 
  | 
|||||||||||
Novartis AG  | 
  | 
  | 
0  | 
100  | 
% | |||||||
        | 
  | 
|||||||||||
        | 
  | 
  | 
        | 
        | 
% | 
| Signature | Digitally Signed By: Rawson Hart  | 
Date | 3/17/2015 3:45:53 PM  |